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Background
This report was received from a physician via Medicines




A 79-old-year female patient was taking Trimosul (INN:
sulfamethoxazole / trimethoprim) 400 mg / 80 mg
tablets 2 tablets twice daily from 2012-Jan-05 to 2012-
Jan-09 for urinary tract infection. On 2012-Jan-09 her
total leukocyte count decreased. The suspected drug
was withdrawn and her leukocyte count gradually
increased. The patient had no previous history of any
drug allergy. Laboratory test showed low level of folic
acid 1.5 ng/mL (ref. values 2.7-3.4 ng/mL). Concomitant
medication was Farin (INN: warfarin) 1 mg daily for
pulmonary embolism since 2012-Jan-02 and Ranisan
(INN: ranitidine) 150 mg twice daily for gastritis since
2011-Dec-27.
Conclusions
This case was classified as serious. The causal relation-
ship between sulfamethoxazole / trimethoprim and the
suspected adverese reaction was assessed as possibly
related based on the temporal association and the
known safety profile of the drug. The suspected adverse
reactions is listed according to the current Reference
Safety Information (RSI). This case does not change the
overall benefit-risk balance of the medicinal product.
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